Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains

European Journal of Immunology

Volumn 35, Issue 11, 2005, Pages 3364-3375

  Ma, Liang ^a   Chan, Kwok Wah ^a   Trendell Smith, Nigel J ^a   Wu, Adrian ^a   Tian, Lina ^a   Lam, Audrey C ^a   Chan, Albert K ^a   Lo, Chi Kin ^a   Chik, Stanley ^a   Ko, King Hung ^a   To, Christina K W ^a   Kam, Siu Kee ^a   Li, Xiao Song ^a   Yang, Cui Hong ^a   Leung, Suet Yi ^a   Ng, Mun Hon ^a   Stott, David I ^b   MacPherson, G Gordon ^c   Huang, Fang Ping ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apoptotic cells; Autoimmunity; Dendritic cells; Lupus; Necrotic cells

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; WILD TYPE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; AUTOIMMUNE DISEASES; CYTOKINES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; DNA; ERYTHEMA; FACE; FEMALE; HUMANS; KIDNEY; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; NECROSIS; PROTEINURIA; SKIN ULCER;

EID: 27944460001     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535192     Document Type: Article

References (46)

1. Kotzin, B. L. and O'Dell, J. R., Systemic lupus erythematosus. In: Frank, M. M., Austen, K. F., Claman, H. N., Unanue, E. R. (Eds.) Samter's Immunologic Diseases, 5th edn. Little, Brown & Co., Boston 1995, pp 667-697.
2. Swaak, A. J., Groenwold, J., Aarden, L. A., Statius van Eps, L. W. and Feltkamp, E. W., Prognostic value of anti-dsDNA in SLE. Ann. Rheum. Dis. 1982. 41: 388-395.
3. Herrmann, M., Zoller, O. M., Hagenhofer, M., Voll, R. and Kalden, J. R., What triggers anti-dsDNA antibodies? Mol. Biol. Rep. 1996. 23: 265-267.
4. Madaio, M. P., Hodder, S., Schwartz, R. S. and Stollar, B. D., Responsiveness of autoimmune and normal mice to nucleic acid antigens. J. Immunol. 1984. 132: 872-876.
5. Wun, H. L., Leung, D. T., Wong, K. C., Choi, Y. L. and Lim, P. L., Molecular mimicry: anti-DNA antibodies may arise inadvertently as a response to antibodies generated to microorganisms. Int. Immunol. 2001. 13: 1099-1107.
6. Isenberg, D. and Shoenfeld, Y., Autoantibodies, idiotypes, anti-idiotypes and autoimmunity. Acta Haematol. 1986. 76: 95-100.
7. Matzinger, P., An innate sense of danger. Semin. Immunol. 1998. 10: 399-415.
8. Rodenburg, R. J., Raats, J. M., Pruijn, G. J. and van Venrooij, W. J., Cell death: a trigger of autoimmunity? Bioessays 2000. 22: 627-636.
9. Mevorach, D., Zhou, J. L., Song, X. and Elkon, K. B., Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 1998. 188: 387-392.
10. Matzinger, P., The danger model: a renewed sense of self. Science 2002. 296: 301-305.
11. Kalden, J. R., Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 1997. 6: 326-327.
12. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998. 392: 86-89.
13. Theofilopoulos, A. N. and Dixon, F. J., Murine models of systemic lupus erythematosus. Adv. Immunol. 1985. 37: 269-390.
14. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
15. Morrow, J., Nelson, L., Watts, R. and Isenberg, D., Systemic lupus erythematosus. Autoimmune rheumatoid disease., 2nd edn. Oxford University Press, Oxford 1999, pp 56-103.
16. Esfandiari, E., McInnes, I. B., Lindop, G., Huang, F. P., Field, M., Komai-Koma, M., Wei, X. and Liew, F. Y., A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J. Immunol. 2001. 167: 5338-5347.
17. Weedon, D., Diseases of cutaneous apendages-Alopecias.In Skin Pathology, 2nd edn. Churchill Livingstone/Elsevier, Philadelphia 2002, pp 471-480.
18. Messenger, A. G., Slater, D. N. and Bleehen, S. S., Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br. J. Dermatol. 1986. 114: 337-347.
19. Correia, P., Cameron, J. S., Lian, J. D., Hicks, J., Ogg, C. S., Williams, D. G., Chantler, C. and Haycock, D. G., Why do patients with lupus nephritis die? Br. Med. J. 1985. 290: 126-131.
20. Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffman, R. L., Mosmann, T. R. and Vitetta, E. S., Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988. 334: 255-258.
21. Rook, G. A. and Stanford, J. L., Slow bacterial infections or autoimmunity? Immunol. Today 1992. 13: 160-164.
22. Gallucci, S., Lolkema, M. and Matzinger, P., Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999. 5: 1249-1255.
23. Shi, Y., Evans, J. E. and Rock, K. L., Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003. 425: 516-521.
24. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., Stevenson, M. A. and Calderwood, S. K., Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002. 277: 15028-15034.
25. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K. et al., Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 2002. 195: 99-111.
26. Mevorach, D., Mascarenhas, J. O., Gershov, D. and Elkon, K. B., Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 1998. 188: 2313-2320.
27. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998. 101: 890-898.
28. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N., Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000. 191: 423-434.
29. Melcher, A., Gough, M., Todryk, S. and Vile, R., Apoptosis or necrosis for tumor immunotherapy: what's in a name? J. Mol. Med. 1999. 77: 824-833.
30. Bondanza, A., Zimmermann, V. S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M. G., Manfredi, A. A. and Rovere-Querini, P., Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 2003. 170: 24-27.
31. Ip, W. K. and Lau, Y. L., Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 2004. 173: 189-196.
32. Farkas, A. I., Medgyesi, G. A., Fust, G., Miklos, K. and Gergely, J., Immunogeniciiy of antigen complexed with antibody. I. Role of different isotypes. Immunology 1982. 45: 483-492.
33. Daeron, M., Couderc, J., Ventura, M., Liacopoulos, P. and Voisin, G. A., Anaphylactic properties of mouse monoclonal IgG2a antibodies. Cell. Immunol. 1982. 70: 27-40.
34. Kunkl, A. and Klaus, G. G., The generation of memory cells. V. Preferential priming of IgG1 B memory cells by immunization with antigen IgG2 antibody complexes. Immunology 1981. 44: 163-168.
35. Steward, M. W. and Hay, F. C., Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin. Exp. Immunol. 1976. 26: 363-370.
36. Bijl, M., Dijstelbloem, H. M., Cost, W. W., Bootsma, H., Derksen, R. H., Aten, J., Limburg, P. C. and Kallenberg, C. G., IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2002. 41: 62-67.
37. Georgiev, M., Agle, L. M., Chu, J. L., Elkon, K. B. and Ashany, D., Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum. 2005. 52: 225-238.
38. Huang, F. P., Feng, G. J., Lindop, G., Stott, D.I. and Liew, F. Y., The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLμP-lprłpr mice. J. Exp. Med. 1996. 183: 1447-1459.
39. Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J. and Koyasu, S., IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 2001. 22: 556-560.
40. Banchereau, J., Pascual, V. and Palucka, A. K., Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004. 20: 539-550.
41. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 1540-1543.
42. Wilder, R. L. and Elenkov, I. J., Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann. N. Y. Acad. Sci. 1999. 876: 14-31.
43. Vyse, T. J. and Kotzin, B. L., Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol. 1998. 16: 261-292.
44. Izui, S., Kelley, V. E., Masuda, K., Yoshida, H., Roths, J. B. and Murphy, E. D., Induction of various autoantibodies by mutant gene 1pr in several strains of mice. J. Immunol. 1984. 133: 227-233.
45. Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A. et al., Genetic analysis of MRL-1pr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 1992. 176: 1645-1656.
46. Rubin, R. L., Enzyme-linked immunosorbent assay for anti-DNA and anti-histone antibodies including anti(H2A-H2B).In Rose, N. R., de Macario, E. C., Fahey, J. L., Friedman, H. and Penn, G. M. (Eds.) Manual of Clinical Laboratory Immunology.ASM Press, Washington D. C. 2002, pp 735-740.